Bio Tech & Pharma InhaleRx Secures $38.5 Million in Funding to Support Clinical Development InitiativesBy Alexander LeeOctober 21, 20240 The commitment to advancing the development of bexicaserin for patients with Developmental and Epileptic Encephalopathies (DEEs) is emphasized by Dr.…
Bio Tech & Pharma BCAL Initiates Operations in the United StatesBy Alexander LeeAugust 28, 20240 BCAL has initiated operations in the United States, expanding its presence into the American market.
Bio Tech & Pharma Phase 2 Sleep Signal Analysis Yields Encouraging Outcomes in SAMDE Study on Current Major Depressive EpisodeBy Alexander LeeAugust 16, 20240 The Phase 1a trial of SZN-043 showed evidence of target engagement and Wnt-pathway mediated pharmacodynamic effects in the liver. Enrollment…
Bio Tech & Pharma Phase 2 Sleep Signal Analysis Yields Encouraging Outcomes in SAMDE Study on Current Major Depressive EpisodeBy Alexander LeeAugust 16, 20240 A Phase 1a trial of SZN-043 has shown promising results, indicating target engagement and Wnt-pathway mediated pharmacodynamic effects in the…
